Cefpodoxime Proxetil 40 mg/5 ml

Business Unit: Human

Medicine Type: Dry Syrup

Generic Name: Cefpodoxime Proxetil 40 mg/5 ml

Therapeutic Class: Third Generation Cephalosporins

Indication: Cefpodoxime is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. Cefpodoxime treats only bacterial infections. Podoxi (Cefpodoxime Proxetil USP) is indicated for the treatment of infections caused by susceptible microorganism, listed below: Acute otitis media, Pharyngitis/tonsillitis, Acute maxillary sinusitis, Community acquired pneumonia, Acute bacterial exacerbation of chronic bronchitis, Skin and skin structure infections, Uncomplicated urinary tract infections, Uncomplicated gonorrhea, Rectal gonococcal infections in women.

Dosage & Administration: Adults and Adolescents (13 years and older) • Pharyngitis/tonsillitis: 100 mg 12 hourly, 5 to 10 days • Acute maxillary sinusitis: 200 mg 12 hourly, 10 day • Community acquired pneumonia: 200 mg 12 hourly, 14 days • Acute bacterial exacerbations of chronic bronchitis: 200 mg 12 hourly, 10 days • Skin and skin structure: 400 mg 12 hourly, 7 to 14 days • Uncomplicated urinary tract infection: 100 mg 12 hourly, 7 days • Uncomplicated gonorrhea: single dose of 200 mg • Rectal gonococcal infections in women: single dose of 200 mg Infants and Pediatric Patients (2 months to 12 years) • Acute otitis media: 5 mg/kg body weight 12 hourly, 5 days • Pharyngitis /tonsillitis: 5 mg/kg body weight 12 hourly, 5 to 10 days • Acute maxillary sinusitis: 5 mg/kg body weight 12 hourly, 10 days

Preparation: 50 ml Dry Syrup